EUVIMEDOpdag EUVIMED
Open access · CC BY-NC-ND 4.0

Synthesis, Bioactivity and Molecular Modeling Studies on Benzimidazole Derivatives and Its Isosteres as Potent AChE / BChE and GSK3β Inhibitors for Alzheimer's Disease

Gözde Sayar, Sulunay Parlar iD, Ayse Hande Tarikogullari, Mumin Alper Erdoğan iD, Guliz Armagan, Vildan Alptuzun iD

Chemical Biology & Drug Design · 2026

DOI: 10.1111/cbdd.70285 ↗

At a glance

Journal article in Chemical Biology & Drug Design, 2026. Written by Gözde Sayar and 5 co-authors. Institution: Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Ege University, Izmir, Turkey. Major MEDLINE topics: Glycogen Synthase Kinase 3 beta, Cholinesterase Inhibitors, Acetylcholinesterase, Benzimidazoles. Cited 3 times so far (Crossref); 55 references. The full text is freely available (open access, CC BY-NC-ND 4.0). Funded by: Ege University Research Foundation.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

A series of benzimidazoles and its analogs (benzoxazoles and benzothiazoles) bearing a benzohydrazide‐hydrazones moiety at the 2‐position were designed and synthesized as potential acetylcholinesterase (AChE) inhibitors. Cholinesterase (ChE) inhibitory activity results showed that all compounds displayed good inhibition of AChE, whereas only some of the compounds were active against BChE. Among the title compounds, it was found that all benzimidazole series were selective towards AChE. Kinetic analysis and molecular modeling studies were conducted on the most active compounds, namely 1j for AChE and 3g for BChE inhibition. The kinetic results showed that the tested compounds exhibited a mixed‐type inhibition mechanism on both enzymes. In cell culture studies, all compounds were evaluated for their neuroprotective effects against hydrogen peroxide (H 2 O 2 )‐induced oxidative stress in the SH‐SY5Y human neuroblastoma cell line. Several compounds demonstrated more than 30% neuroprotection at a low concentration (1 μM) in the presence of H 2 O 2 . Selected compounds, chosen based on their EC 50 values, were further examined for their effects on glycogen synthase kinase‐3 beta (GSK3β), an enzyme whose activity has been reported to be increased in the brains of patients with Alzheimer's disease (AD). The inhibition of GSK3β was assessed by measuring phosphorylated GSK3β (pGSK3β, Ser9) protein expression via Western Blot analysis under oxidative stress conditions. Among the tested compounds, 1l , 2b , 2j , and 3l significantly increased pGSK3β (Ser9) protein levels compared to cells treated with tideglusib, a known GSK3β inhibitor.

Subjects

MeSH terms (MEDLINE)

Glycogen Synthase Kinase 3 betaCholinesterase InhibitorsAcetylcholinesteraseBenzimidazolesButyrylcholinesteraseNeuroprotective AgentsHumansAlzheimer DiseaseCell Line, TumorHydrogen PeroxideGlycogen Synthase Kinase 3Models, MolecularOxidative StressMolecular Docking SimulationKinetics

Author keywords

AChE/BChE inhibitionAlzheimer's diseaseGSK3β inhibitionhydrazide‐hydrazonemolecular modelingsynthesis

Substances

Glycogen Synthase Kinase 3 betaCholinesterase InhibitorsAcetylcholinesteraseBenzimidazolesHydrogen PeroxideButyrylcholinesteraseGSK3B protein, humanNeuroprotective AgentsGlycogen Synthase Kinase 3

Authors and institutions

  • Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Ege University, Izmir, Turkey.
  • Department of Physiology, School of Medicine, Katip Celebi University, Izmir, Turkey.
  • Department of Biochemistry, Faculty of Pharmacy, Ege University, Izmir, Turkey.

ORCID profiles: Sulunay Parlar, Mumin Alper Erdoğan, Vildan Alptuzun

Funding

  • Ege University Research Foundation

Cite

APA

Sayar, G., Parlar, S., Tarikogullari, A. H., Erdoğan, M. A., Armagan, G., & Alptuzun, V. (2026). Synthesis, Bioactivity and Molecular Modeling Studies on Benzimidazole Derivatives and Its Isosteres as Potent AChE / BChE and GSK3β Inhibitors for Alzheimer's Disease. Chemical Biology & Drug Design. https://doi.org/10.1111/cbdd.70285

Vancouver

Sayar G, Parlar S, Tarikogullari AH, Erdoğan MA, Armagan G, Alptuzun V. Synthesis, Bioactivity and Molecular Modeling Studies on Benzimidazole Derivatives and Its Isosteres as Potent AChE / BChE and GSK3β Inhibitors for Alzheimer's Disease. Chemical Biology & Drug Design. 2026. doi:10.1111/cbdd.70285

BibTeX
@article{Sayar2026,
  author = {Sayar, Gözde and Parlar, Sulunay and Tarikogullari, Ayse Hande and Erdoğan, Mumin Alper and Armagan, Guliz and Alptuzun, Vildan},
  title = {Synthesis, Bioactivity and Molecular Modeling Studies on Benzimidazole Derivatives and Its Isosteres as Potent AChE / BChE and GSK3β Inhibitors for Alzheimer's Disease},
  journal = {Chemical Biology & Drug Design},
  year = {2026},
  doi = {10.1111/cbdd.70285}
}
Start for free →